Frontiers in Human Neuroscience (Mar 2020)

Proceedings of the Seventh Annual Deep Brain Stimulation Think Tank: Advances in Neurophysiology, Adaptive DBS, Virtual Reality, Neuroethics and Technology

  • Adolfo Ramirez-Zamora,
  • James Giordano,
  • Aysegul Gunduz,
  • Aysegul Gunduz,
  • Jose Alcantara,
  • Jose Alcantara,
  • Jackson N. Cagle,
  • Jackson N. Cagle,
  • Stephanie Cernera,
  • Stephanie Cernera,
  • Parker Difuntorum,
  • Parker Difuntorum,
  • Robert S. Eisinger,
  • Robert S. Eisinger,
  • Julieth Gomez,
  • Julieth Gomez,
  • Sarah Long,
  • Sarah Long,
  • Brandon Parks,
  • Brandon Parks,
  • Joshua K. Wong,
  • Shannon Chiu,
  • Bhavana Patel,
  • Warren M. Grill,
  • Harrison C. Walker,
  • Harrison C. Walker,
  • Simon J. Little,
  • Ro’ee Gilron,
  • Gerd Tinkhauser,
  • Gerd Tinkhauser,
  • Wesley Thevathasan,
  • Wesley Thevathasan,
  • Wesley Thevathasan,
  • Nicholas C. Sinclair,
  • Nicholas C. Sinclair,
  • Andres M. Lozano,
  • Thomas Foltynie,
  • Alfonso Fasano,
  • Alfonso Fasano,
  • Sameer A. Sheth,
  • Katherine Scangos,
  • Terence D. Sanger,
  • Jonathan Miller,
  • Audrey C. Brumback,
  • Priya Rajasethupathy,
  • Priya Rajasethupathy,
  • Cameron McIntyre,
  • Leslie Schlachter,
  • Nanthia Suthana,
  • Cynthia Kubu,
  • Lauren R. Sankary,
  • Karen Herrera-Ferrá,
  • Steven Goetz,
  • Binith Cheeran,
  • G. Karl Steinke,
  • Christopher Hess,
  • Leonardo Almeida,
  • Wissam Deeb,
  • Kelly D. Foote,
  • Michael S. Okun

DOI
https://doi.org/10.3389/fnhum.2020.00054
Journal volume & issue
Vol. 14

Abstract

Read online

The Seventh Annual Deep Brain Stimulation (DBS) Think Tank held on September 8th of 2019 addressed the most current: (1) use and utility of complex neurophysiological signals for development of adaptive neurostimulation to improve clinical outcomes; (2) Advancements in recent neuromodulation techniques to treat neuropsychiatric disorders; (3) New developments in optogenetics and DBS; (4) The use of augmented Virtual reality (VR) and neuromodulation; (5) commercially available technologies; and (6) ethical issues arising in and from research and use of DBS. These advances serve as both “markers of progress” and challenges and opportunities for ongoing address, engagement, and deliberation as we move to improve the functional capabilities and translational value of DBS. It is in this light that these proceedings are presented to inform the field and initiate ongoing discourse. As consistent with the intent, and spirit of this, and prior DBS Think Tanks, the overarching goal is to continue to develop multidisciplinary collaborations to rapidly advance the field and ultimately improve patient outcomes.

Keywords